Your session is about to expire
← Back to Search
Health Communication for HIV/AIDS and Hepatitis C
N/A
Recruiting
Led By Roland C Merchant, MD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1, up to 5 minutes after intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial will assess how a brief persuasive health communication intervention can increase HIV/HCV screening acceptance among ED patients who initially declined. It will compare two delivery forms of this intervention, by a video or HIV/HCV counselor, and assess its efficacy among different injection-drug use history cohorts.
Who is the study for?
This trial is for adults over 18 who speak English or Spanish, have not been tested for HIV/HCV in the past year, and are not currently infected with or being treated for these viruses. It's aimed at those who initially declined testing in the emergency department.
What is being tested?
The study tests a persuasive health communication intervention to increase acceptance of HIV/HCV screening. Participants will be randomly assigned to receive this intervention either through a video or directly from an HIV/HCV counselor.
What are the potential side effects?
Since the interventions involve educational content delivered by video or counselor without medical procedures, there are no direct physical side effects expected from participating in this trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1, up to 5 minutes after intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1, up to 5 minutes after intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of patients who accept HIV/HCV testing after speaking with a health educator
Number of patients who accept HIV/HCV testing after watching the video with captions
Number of patients who accept HIV/HCV testing after watching the video without captions
Secondary study objectives
Health economics assessment of PHCI
The number of patients that accept HIV/HCV testing by current injection-drug use
The number of patients that accept HIV/HCV testing by former injection-drug use
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Active Control
Group I: Persuasive Health Communication Intervention delivered in video format with captionsActive Control1 Intervention
A video with captions created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.
Group II: Persuasive Health Communication Intervention delivered in video format without captionsActive Control1 Intervention
A video with captions created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.
Group III: Persuasive Health Communication Intervention delivered by Health EducatorActive Control1 Intervention
Healthcare provider educator getting patients screened for HIV/HCV.
Find a Location
Who is running the clinical trial?
Icahn School of Medicine at Mount SinaiLead Sponsor
913 Previous Clinical Trials
570,801 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,606 Previous Clinical Trials
3,327,869 Total Patients Enrolled
Roland C Merchant, MDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
2 Previous Clinical Trials
1,625 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can speak English or Spanish and can consent to participate.I am 18 years old or older.I am under 18 years old.I cannot speak Spanish or English.
Research Study Groups:
This trial has the following groups:- Group 1: Persuasive Health Communication Intervention delivered in video format with captions
- Group 2: Persuasive Health Communication Intervention delivered in video format without captions
- Group 3: Persuasive Health Communication Intervention delivered by Health Educator
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.